Drug intelligence / Profile preview

PRRS Inactivated Vaccine (CH-1a strain)

Development stage: Unknown
Lead developer: Jinyu Youbang Biotech
Modality: Vaccines & Immunotherapeutics
Administration: Intramuscular

Overview

PRRS Inactivated Vaccine (CH-1a strain) is a veterinary vaccine developed by Youbang Pharmaceutical (a subsidiary of Jinyu Bio-Technology) for the prevention of Porcine Reproductive and Respiratory Syndrome (PRRS), commonly known as blue ear disease, in swine. The vaccine is formulated using the inactivated CH-1a strain of the Porcine Reproductive and Respiratory Syndrome Virus (PRRSV). It is designed to stimulate active immunity against PRRSV, providing a protective period of up to 6 months. The vaccine is approved and marketed in China.

Other names: PRRS inactivated vaccine猪繁殖与呼吸综合征灭活疫苗(CH-1a株)

Targets

IL1B (Interleukin-1 beta)Porcine reproductive and respiratory syndrome virus nucleocapsid protein

Beyond the preview

Go deeper on PRRS Inactivated Vaccine (CH-1a strain).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PRRS Inactivated Vaccine (CH-1a strain).